Investigating the Genetic Landscape of Cerebral Palsy

研究脑瘫的遗传景观

基本信息

  • 批准号:
    10609927
  • 负责人:
  • 金额:
    $ 23.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Cerebral palsy (CP) is the most common childhood-onset motor disability, affecting 764,000 individuals in the United States alone. The lifetime medical costs for a single individual with CP are estimated at $1.4M, which represents a substantial healthcare and economic impact. A diverse set of risk factors contributes to CP, including prematurity, intrauterine infection, and hypoxic ischemic encephalopathy. In approximately 20% of cases, there are no clear perinatal risk factors (“cryptogenic CP”). There is accumulating evidence from rare familial cases and a growing number of isolated cases suggesting that cryptogenic CP may result in part from single gene disorders, including over 50 treatable inborn errors of metabolism. However, these studies have involved small numbers of participants, with patient populations characterized using administrative data with limited attention to precise clinical characterization. The full breadth of the genetic landscape of CP is unknown. We hypothesize that a substantial portion of individuals with cryptogenic CP will have a pathogenic or likely pathogenic variant in a single gene providing an explanation for their symptoms. We propose rigorously phenotyping a large prospective cohort of individuals with both cryptogenic and non-cryptogenic CP who have undergone exome sequencing through an institutional genomics pilot study, and then analyzing exome sequencing data to determine the presence of single gene disorders in each subgroup. To accomplish these goals, we will classify patients as cryptogenic CP or non-cryptogenic CP. We will systematically, rigorously, and longitudinally characterize neurological, motor, communication, and neuroimaging phenotypes using research measures validated for CP. Next, we will analyze exome data using an institutional pipeline for variant interpretation. Finally, we will build a statistical model that correlates the presence of a genetic disorder with phenotypic measures in order to help predict which individuals with CP are most likely to have a single gene disorder. If applied to the population at large, the proposed work could lead to identification of single gene disorders in thousands of individuals with CP, including treatable conditions where a molecular diagnosis may positively alter a child's developmental trajectory. Determining etiology represents a first step in understanding the biological substrates of CP needed for developing rational therapeutics for this highly prevalent condition.
项目总结/摘要 脑性瘫痪(CP)是最常见的儿童期发作的运动障碍,影响764,000人 仅在美国。一个患有CP的个体的终身医疗费用估计为140万美元, 这代表了实质性的医疗保健和经济影响。多种风险因素导致CP, 包括早产、宫内感染和缺氧缺血性脑病。约20%的 例,没有明确的围产期危险因素(“隐源性CP”)。越来越多的证据表明 家族性病例和越来越多的孤立病例表明,隐源性CP可能部分由 单基因疾病,包括超过50种可治疗的先天性代谢缺陷。然而,这些研究 涉及少量参与者,患者人群使用管理数据进行表征, 对精确临床表征的关注有限。CP的遗传景观的全部宽度是 未知 我们假设,相当一部分隐源性CP患者将有致病性或 一个可能的致病性变异的单一基因提供了解释他们的症状。我们严格建议 表型分析一个大型的隐源性和非隐源性CP患者前瞻性队列, 通过机构基因组学试点研究进行外显子组测序,然后分析外显子组 测序数据,以确定每个亚组中单基因疾病的存在。 为了实现这些目标,我们将患者分类为隐源性CP或非隐源性CP。我们将 系统、严格和纵向表征神经、运动、通信和 神经影像学表型使用的研究措施验证CP。接下来,我们将使用 一个机构的管道,为不同的解释。最后,我们将建立一个统计模型, 存在遗传性疾病与表型措施,以帮助预测哪些个人与CP是 最有可能患有单基因疾病 如果应用于整个人群,这项工作可能会导致单个基因的识别, 成千上万的CP患者的疾病,包括分子诊断可以治疗的疾病, 积极地改变孩子的发展轨迹。确定病因是了解 为这种高度流行的疾病开发合理的治疗方法所需的CP生物基质。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Siddharth Srivastava其他文献

Siddharth Srivastava的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Siddharth Srivastava', 18)}}的其他基金

Investigating the Genetic Landscape of Cerebral Palsy
研究脑瘫的遗传景观
  • 批准号:
    10408839
  • 财政年份:
    2021
  • 资助金额:
    $ 23.01万
  • 项目类别:
Investigating the Genetic Landscape of Cerebral Palsy
研究脑瘫的遗传景观
  • 批准号:
    10301468
  • 财政年份:
    2021
  • 资助金额:
    $ 23.01万
  • 项目类别:

相似海外基金

How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
  • 批准号:
    479005
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
    Operating Grants
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
  • 批准号:
    10741382
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
  • 批准号:
    23K06161
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
  • 批准号:
    10799992
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
  • 批准号:
    10607414
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
  • 批准号:
    10753403
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
  • 批准号:
    10668768
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
  • 批准号:
    10579736
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
  • 批准号:
    10754319
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    $ 23.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了